Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The clinical trial details are not available on the page.
    Difference
    1%
    Check dated 2026-10-26T15:56:58.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T20:49:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T03:50:31.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual content with an access-denied message. This prevents viewing the trial details and related information.
    Difference
    18%
    Check dated 2026-09-21T22:54:13.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's versioning metadata rather than to its content.
    Difference
    0.1%
    Check dated 2026-08-31T17:46:03.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.4 to v3.6.5, signaling a small deployment or patch rather than content updates.
    Difference
    0.1%
    Check dated 2026-08-10T15:35:36.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.